Rimouski, Canada Clinical Trials

A listing of Rimouski, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 18 clinical trials
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab Followed by Maintenance Durvalumab Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients

This is a Phase III randomised, double-blind, multi-centre study to evaluate the efficacy and safety of durvalumab in combination with standard of care platinum based chemotherapy and bevacizumab followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian cancer.

Research Site
 (0.8 away) Contact site
  • 84 views
  • 31 Jul, 2021
  • +292 other locations
Impact of 2.0g Daily of MAG-EPA on the AA/EPA Ratio and Inflammation Biomarkers in a Healthy Population Aged of 50+.

According to scientific literature, oils containing omega-3 fatty acids may decrease certain risk factors for cardiovascular disease such as blood pressure, blood level of triglycerides (TGs) and cholesterol. The omega-3 index (amount of EPA + DHA in the blood) is a recognized biomarker for assessing risk factors for cardiovascular disease. …

omega-3 fatty acids
fatty acids
eicosapentaenoic acid
cardiovascular disease
SCF Pharma
 (5.4 away) Contact site
  • 0 views
  • 11 Jun, 2021
  • +1 other locations
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-Positive HER2-Negative Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

The purpose of this study is to evaluate the efficacy of zolbetuximab plus capecitabine and oxaliplatin (CAPOX) compared with placebo plus CAPOX (as first-line treatment) as measured by Progression Free Survival (PFS). This study will also evaluate efficacy, safety and tolerability of zolbetuximab, as well as its effects on quality …

Site CA15003
 (119.1 away) Contact site
  • 224 views
  • 04 Aug, 2021
  • +207 other locations
A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Assessment of PF-06700841 in participants with moderate to severe active, generalized Systemic Lupus Erythematosus (SLE) that have inadequate response to standard of care.

corticosteroids
lupus
leflunomide
methotrexate
mycophenolate
Centre int gr de sant et de services sociaux du Bas-Saint-Laurent - H pital r gional de Rim
 (0.8 away) Contact site
  • 198 views
  • 04 Aug, 2021
  • +224 other locations
A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis

This study consists of two periods. The objective of Period 1 is to evaluate the efficacy of upadacitinib in combination with a 26-week corticosteroid (CS) taper regimen compared to placebo in combination with a 52-week CS taper regimen, as measured by the proportion of participants in sustained remission at Week …

CISSSBSL -Hopital regional de Rimouski /ID# 224266
 (0.8 away) Contact site
  • 311 views
  • 01 Aug, 2021
  • +302 other locations
Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sj gren's Syndrome

This study will evaluate safety, efficacy, pharmacokinetics (PK) and pharmacodynamics (PD) of multiple doses of CFZ533 (iscalimab) in patients with Sjgren's Syndrome.

fatigue
Novartis Investigative Site
 (0.8 away) Contact site
  • 100 views
  • 26 Jul, 2021
  • +74 other locations
TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833 PF-06651600 AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE

Dual objectives of increased efficacy compared to currently available SoC RA drugs and maintaining a favourable benefit - risk relationship.

erythrocyte sedimentation
high sensitivity
tofacitinib
methotrexate
rheumatism
Centre de Rhumatologie de l'Est du Quebec (CREQ)
 (0.6 away) Contact site
  • 17 views
  • 03 Aug, 2021
  • +180 other locations
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

The purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long term improvement of moderate to severe disease activity.

corticosteroids
immunosuppressive agents
sjogren's syndrome
lupus
rheumatism
Sl00043 50044
 (235.9 away) Contact site
  • 10 views
  • 31 Jul, 2021
  • +144 other locations
A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis

This is a study to demonstrate the clinical efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared with placebo in the treatment of tumor necrosis factor alpha-inadequate responders (TNF-IR) subjects with active Psoriatic Arthritis (PsA).

corticosteroids
rheumatoid factor
steroidal anti-inflammatory drugs
tumor necrosis factor alpha
arthritis
Pa0011 50041
 (167.0 away) Contact site
  • 428 views
  • 04 Aug, 2021
  • +217 other locations
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

The purpose of this study is to assess the efficacy and safety of the combination of pembrolizumab (MK-3475) and enzalutamide in the treatment of men with metastatic castration-resistant prostate cancer (mCRPC) who have not received chemotherapy for mCRPC, are abiraterone-nave, or are intolerant to or progressed on abiraterone acetate. There …

testosterone
tumor progression
cancer
abiraterone
castration-resistant prostate cancer
CIUSSS du Bas Saint Laurent - Hopital Regional de Rimouski ( Site 0102)
 (0.8 away) Contact site
  • 506 views
  • 04 Aug, 2021
  • +248 other locations